NeXT Personal Archives - PharmaDeviceNews

Can ultrasensitive ctDNA monitoring reshape how clinicians track neoadjuvant breast cancer therapy response?

By Pallavi Madhiraju on March 15, 2026 Medical Devices & Diagnostics

New PREDICT-DNA data suggests ultrasensitive ctDNA monitoring may outperform traditional markers in breast cancer relapse prediction. Read the full analysis.

What the TRACERx study reveals about Personalis’ MRD technology in NSCLC

By Pallavi Madhiraju on December 13, 2025 Medical Devices & Diagnostics

Personalis, Inc. has reported pivotal findings from its NeXT Personal assay in a new Cell publication, highlighting the test’s ability to detect molecular residual disease in stage I to III non-small cell lung cancer. The study, part of the TRACERx initiative and led by Professor Charles Swanton of the Francis Crick Institute and University College […]